Pesquisa | SciELO

Precisa de ajuda?

Adicionar outro campo +

Histórico de busca

Não foram encontrados documentos para sua pesquisa

Resultados: 9

au:Lobo, Clarisse Lopes de Castro

Filtros

Coleções + Opções

Todos
Brasil

8
Saúde Pública

1

Periódico + Opções

Todos
Revista Brasileira de Hematologia e Hemoterapia

5
Hematology, Transfusion and Cell Therapy

3
Revista Panamericana de Salud Pública

1

Idioma

Todos
Português

1

Ano de publicação + Opções

Todos
2013

2
2021

2
2003

1
2011

1
2012

1
2014

1
2018

1

SciELO Áreas Temáticas

Todos
Ciências da Saúde

9

WoS Áreas Temáticas + Opções

Todos
Medicine

8
Experimental

5
Hematologia

5
Research

5
General

3
Internal

3
Health

1
Policy

1
Services

1

WoS Índice de Citações

Todos
Social Sciences Citation Index

3

Citáveis e não citáveis + Opções

Todos
Citável

7
Não citável

2

Tipo de literatura + Opções

Todos
Artigo

7
Carta

2

Ordenar por

Página de 1 Próxima

Selecionar esta página

Imprimir | Enviar por e-mail | Exportar |

Facebook
Twitter
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Outras redes

0 Itens selecionados

Listar itens
Apagar todos da lista

Menopause in Brazilian women with sickle cell anemia with and without hydroxyurea therapy
Facebook Twitter

Outras redes sociais
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Outras redes

Métricas
- SciELO Analytics
- Dimensions
- PlumX
- Altmetric

Queiroz, Ana Mach

; Lobo, Clarisse Lopes de Castro

; Ballas, Samir K

Hematology, Transfusion and Cell Therapy

Métricas do periódico
- Sobre o periódico
- SciELO Analytics

Set 2021, Volume 43 Nº 3 Páginas 386 - 388

Resumo: En | Texto: En | PDF: En

https://doi.org/10.1016/j.htct.2020.06.009 24 downloads

Consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria
Facebook Twitter

Outras redes sociais
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Outras redes

Métricas
- SciELO Analytics
- Dimensions
- PlumX
- Altmetric

Cançado, Rodolfo D

; Araújo, Aderson da Silva

; Sandes, Alex Freire

; Arrais, Celso

; Lobo, Clarisse Lopes de Castro

; Figueiredo, Maria Stella

; Gualandro, Sandra Fátima Menosi

; Saad, Sara Teresinha Olalla

; Costa, Fernando Ferreira

Hematology, Transfusion and Cell Therapy

Métricas do periódico
- Sobre o periódico
- SciELO Analytics

Set 2021, Volume 43 Nº 3 Páginas 341 - 348

Resumo: En | Texto: En | PDF: En

Paroxysmal nocturnal hemoglobinuria is a chronic, multi-systemic, progressive and lifethreatening disease characterized by intravascular hemolysis, thrombotic events, serious infections and bone marrow failure. Paroxysmal nocturnal hemoglobinuria results from the expansion of a clone of hematopoietic cells that due to an inactivating mutation of the X-linked gene PIG-A are deficient in glycosylphosphatidylinositol-linked proteins. Early diagnosis, using flow cytometry performed on peripheral blood, the gold standard test to confirm the diagnosis of paroxysmal nocturnal hemoglobinuria, is essential for improved patient management and prognosis. The traditional therapy for paroxysmal nocturnal hemoglobinuria includes blood transfusion, anti-thrombosis prophylaxis or allogeneic bone marrow transplantation. The treatment that has recently become available is the complement blockade by the anti-C5 monoclonal antibody eculizumab. In this consensus, we are aiming to review the diagnosis and treatment of the paroxysmal nocturnal hemoglobinuria patients, as well as the early recognition of its systemic complications. These procedures express the opinions of experts and have been based on the best available evidence and international guidelines, with the purpose of increasing benefits and reducing harm to patients.

https://doi.org/10.1016/j.htct.2020.06.006 23 downloads

Mortality in children, adolescents and adults with sickle cell anemia in Rio de Janeiro, Brazil
Facebook Twitter

Outras redes sociais
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Outras redes

Métricas
- SciELO Analytics
- Dimensions
- PlumX
- Altmetric

Lobo, Clarisse Lopes de Castro

; Nascimento, Emilia Matos do

; Jesus, Leonardo José Carvalho de

; Freitas, Thiago Gotelip de

; Lugon, Jocemir Ronaldo

; Ballas, Samir K.

Hematology, Transfusion and Cell Therapy

Métricas do periódico
- Sobre o periódico
- SciELO Analytics

Mar 2018, Volume 40 Nº 1 Páginas 37 - 42

Resumo: En | Texto: En | PDF: En

Abstract Objective: To determine the mortality rate of children, adolescents and adults with sickle cell anemia in Rio de Janeiro, Brazil. Methods: The number of deaths, the mortality rate and the causes of deaths in patients with sickle cell anemia who were treated and followed up at our institution for 15 years were determined and compared to data available for the Brazilian population. Results: The overall number of deaths was 281 patients with a mortality rate of 16.77%. Survival probability was significantly higher in females. The number of deaths and the mortality rate were age-specific with a significant increase in the 19- to 29-year-old age group. The remaining life expectancy of the patients with sickle cell anemia was less than that of Brazilians at large. The gap between the two was about 20 years for ages between one and five years with this gap decreasing to ten years after the age of 65 years. The most common causes of death were infection, acute chest syndrome, overt stroke, organ damage and sudden death during painful crises. Conclusion: To the best of our knowledge, this is the first Brazilian study in a single institution in Rio de Janeiro; the mortality rate was 18.87% among adult patients with sickle cell anemia. The mortality rates in children and adults are higher than those reported in developed countries of the northern hemisphere.

https://doi.org/10.1016/j.bjhh.2017.09.006 1485 downloads

Guidelines on the treatment of anemia of chronic renal failure using recombinant human erythropoietin: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira – 2014
Facebook Twitter

Outras redes sociais
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Outras redes

Métricas
- SciELO Analytics
- Dimensions
- PlumX
- Altmetric

Araújo, Aderson da Silva

; Lobo, Clarisse Lopes de Castro

; Covas, Dimas Tadeu

; Costa, Fernando Ferreira

; Medeiros, Letícia

; Cançado, Rodolfo Delfini

; Gualandro, Sandra Fátima Menosi

; Saad, Sara Teresinha Olalla

Revista Brasileira de Hematologia e Hemoterapia

Métricas do periódico
- Sobre o periódico
- SciELO Analytics

Dez 2014, Volume 36 Nº 6 Páginas 450 - 453

Resumo: En | Texto: En | PDF: En

https://doi.org/10.1016/j.bjhh.2014.09.009 1896 downloads

Brazilian Thalassemia Association protocol for iron chelation therapy in patients under regular transfusion
Facebook Twitter

Outras redes sociais
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Outras redes

Métricas
- SciELO Analytics
- Dimensions
- PlumX
- Altmetric

Verissimo, Monica Pinheiro de Almeida

; Loggetto, Sandra Regina

; Fabron Junior, Antonio

; Baldanzi, Giorgio Roberto

; Hamerschlak, Nelson

; Fernandes, Juliano Lara

; Araujo, Aderson da Silva

; Lobo, Clarisse Lopes de Castro

; Fertrin, Kleber Yotsumoto

; Berdoukas, Vasilios Antonios

; Galanello, Renzo

Revista Brasileira de Hematologia e Hemoterapia

Métricas do periódico
- Sobre o periódico
- SciELO Analytics

2013, Volume 35 Nº 6 Páginas 428 - 434

Resumo: En | Texto: En | PDF: En

In the absence of an iron chelating agent, patients with beta-thalassemia on regular transfusions present complications of transfusion-related iron overload. Without iron chelation therapy, heart disease is the major cause of death; however, hepatic and endocrine complications also occur. Currently there are three iron chelating agents available for continuous use in patients with thalassemia on regular transfusions (desferrioxamine, deferiprone, and deferasirox) providing good results in reducing cardiac, hepatic and endocrine toxicity. These practice guidelines, prepared by the Scientific Committee of Associação Brasileira de Thalassemia (ABRASTA), presents a review of the literature regarding iron overload assessment (by imaging and laboratory exams) and the role of T2* magnetic resonance imaging (MRI) to control iron overload and iron chelation therapy, with evidence-based recommendations for each clinical situation. Based on this review, the authors propose an iron chelation protocol for patients with thalassemia under regular transfusions.

https://doi.org/10.5581/1516-8484.20130106 5074 downloads

Beta-S globin haplotypes in patients with sickle cell anemia: one approach to understand the diversity in Brazil
Facebook Twitter

Outras redes sociais
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Outras redes

Métricas
- SciELO Analytics
- Dimensions
- PlumX
- Altmetric

Okumura, Jéssika Viviani

; Lobo, Clarisse Lopes de Castro

; Bonini-Domingos, Claudia Regina

Revista Brasileira de Hematologia e Hemoterapia

Métricas do periódico
- Sobre o periódico
- SciELO Analytics

2013, Volume 35 Nº 1 Páginas 71 - 72

Resumo: En | Texto: En | PDF: En

https://doi.org/10.5581/1516-8484.20130019 1253 downloads Citado 3 vezes em SciELO

The influence of hydroxyurea on oxidative stress in sickle cell anemia
Facebook Twitter

Outras redes sociais
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Outras redes

Métricas
- SciELO Analytics
- Dimensions
- PlumX
- Altmetric

Torres, Lidiane de Souza

; Silva, Danilo Grünig Humberto da

; Belini Junior, Edis

; Almeida, Eduardo Alves de

; Lobo, Clarisse Lopes de Castro

; Cançado, Rodolfo Delfini

; Ruiz, Milton Artur

; Bonini-Domingos, Claudia Regina

Revista Brasileira de Hematologia e Hemoterapia

Métricas do periódico
- Sobre o periódico
- SciELO Analytics

2012, Volume 34 Nº 6 Páginas 421 - 425

Resumo: En | Texto: En | PDF: En

OBJECTIVE: The oxidative stress in 20 sickle cell anemia patients taking hydroxyurea and 13 sickle cell anemia patients who did not take hydroxyurea was compared with a control group of 96 individuals without any hemoglobinopathy. METHODS: Oxidative stress was assessed by thiobarbituric acid reactive species production, the Trolox-equivalent antioxidant capacity and plasma glutathione levels. RESULTS: Thiobarbituric acid reactive species values were higher in patients without specific medication, followed by patients taking hydroxyurea and the Control Group (p < 0.0001). The antioxidant capacity was higher in patients taking hydroxyurea and lower in the Control Group (p = 0.0002 for Trolox-equivalent antioxidant capacity and p < 0.0292 for plasma glutathione). Thiobarbituric acid reactive species levels were correlated with higher hemoglobin S levels (r = 0.55; p = 0.0040) and lower hemoglobin F concentrations(r = -0.52; p = 0.0067). On the other hand, plasma glutathione levels were negatively correlated with hemoglobin S levels (r = -0.49; p = 0.0111) and positively associated with hemoglobin F values (r = 0.56; p = 0.0031). CONCLUSION: Sickle cell anemia patients have high oxidative stress and, conversely, increased antioxidant activity. The increase in hemoglobin F levels provided by hydroxyurea and its antioxidant action may explain the reduction in lipid peroxidation and increased antioxidant defenses in these individuals.

https://doi.org/10.5581/1516-8484.20120106 2662 downloads Citado 1 vez em SciELO

Brazilian Guidelines for transcranial doppler in children and adolescents with sickle cell disease
Facebook Twitter

Outras redes sociais
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Outras redes

Métricas
- SciELO Analytics
- Dimensions
- PlumX
- Altmetric

Lobo, Clarisse Lopes de Castro

; Cançado, Rodolfo Delfini

; Leite, Ana Claudia Celestino Bezerra

; Anjos, Ana Claudia Mendonça dos

; Pinto, Ana Cristina Silva

; Matta, Andre Palma da Cunha

; Silva, Célia Maria

; Silva, Gisele Sampaio

; Friedrisch, João Ricardo

; Braga, Josefina Aparecida Pellegrini

; Lange, Marcos Christiano

; Figueiredo, Maria Stella

; Rugani, Marília Álvares

; Veloso, Orlando

; Moura, Patrícia Gomes

; Cortez, Paulo Ivo

; Adams, Robert

; Gualandro, Sandra Fátima Menosi

; Castilho, Shirley Lopes de

; Thomé, Ursula

; Zetola, Viviane Flumignan

Revista Brasileira de Hematologia e Hemoterapia

Métricas do periódico
- Sobre o periódico
- SciELO Analytics

Fev 2011, Volume 33 Nº 1 Páginas 43 - 48

Resumo: En | Texto: En | PDF: En

BACKGROUND: Sickle cell disease is the most common monogenic hereditary disease in Brazil. Although strokes are one of the main causes of morbidity and mortality in these patients, the use of transcranial Doppler to identify children at risk is not universally used. OBJECTIVE: To develop Brazilian guidelines for the use of transcranial Doppler in sickle cell disease children and adolescents, so that related health policies can be expanded, and thus contribute to reduce morbidity and mortality. METHODS: The guidelines were formulated in a consensus meeting of experts in transcranial Doppler and sickle cell disease. The issues discussed were previously formulated and scientific articles in databases (MEDLINE, SciELO and Cochrane) were carefully analyzed. The consensus for each question was obtained by a vote of experts on the specific theme. RESULTS: Recommendations were made, including indications for the use of transcranial Doppler according to the sickle cell disease genotype and patients age; the necessary conditions to perform the exam and its periodicity depending on exam results; the criteria for the indication of blood transfusions and iron chelation therapy; the indication of hydroxyurea; and the therapeutic approach in cases of conditional transcranial Doppler. CONCLUSION: The Brazilian guidelines on the use of transcranial doppler in sickle cell disease patients may reduce the risk of strokes, and thus reduce the morbidity and mortality and improve the quality of life of sickle cell disease patients.

https://doi.org/10.5581/1516-8484.20110014 4463 downloads

Triagem neonatal para hemoglobinopatias no Rio de Janeiro, Brasil
Facebook Twitter

Outras redes sociais
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Outras redes

Métricas
- SciELO Analytics

Lobo, Clarisse Lopes de Castro

; Bueno, Leíse Marcelo

; Moura, Patricia

; Ogeda, Leila Loureiro

; Castilho, Shirley

; Carvalho, Silvia Maia Farias de

Revista Panamericana de Salud Pública

Métricas do periódico
- Sobre o periódico
- SciELO Analytics

Mar 2003, Volume 13 Nº 2-3 Páginas 154 - 159

Resumo: Pt En | Texto: Pt En | PDF: Pt | PDF: En

OBJETIVO: Descrever os principais resultados do programa de triagem neonatal para a doença falciforme do Estado do Rio de Janeiro em 15 meses de funcionamento (agosto de 2000 a novembro de 2001). MÉTODOS: A partir de agosto de 2000, amostras de sangue passaram a ser coletadas de todos os recém-nascidos atendidos em postos de atenção básica à saúde no Estado para triagem neonatal da doença falciforme. Essas amostras são submetidas a cromatografia líquida de alta resolução. Se o cromatograma resultante for compatível com a doença falciforme, a criança e seus pais são encaminhados para confirmação diagnóstica e tratamento. RESULTADOS: De agosto de 2000 a novembro de 2001, 99 260 recém nascidos participaram da triagem. Houve um caso de homozigose para Hb C. Um em cada 27 recém-nascidos triados pelo programa apresentou o traço falciforme (Hb AS). A doença falciforme foi constatada em 83 casos (um caso novo para cada 1 196 nascimentos): 62 Hb S, 18 Hb SC, 3 Hb SD. Uma criança não compareceu para confirmação diagnóstica. As 82 crianças acompanhadas apresentaram 15 intercorrências (infecções de vias aéreas superiores, febre, seqüestro esplênico, síndrome mão-pé e crises de vaso-oclusão), motivando sete internações. Houve necessidade de transfusão sangüínea em 15 crianças, mas nenhuma tornou-se alo-imunizada. Os demais bebês estão evoluindo satisfatoriamente com o uso de penicilina profilática. CONCLUSÕES: Nossos dados evidenciam a importância do diagnóstico precoce da doença falciforme, de forma a prevenir e evitar as freqüentes complicações infecciosas enfrentadas por esses pacientes.

OBJECTIVE: To describe the main results obtained in the first 15 months of neonatal screening for sickle cell disease in the state of Rio de Janeiro, Brazil, from August 2000 to November 2001. METHODS: Starting in August 2000, blood samples began to be collected for sickle cell disease screening from all newborns receiving care in primary health care clinics in the state of Rio de Janeiro. The samples were submitted to high-resolution liquid chromatography. If the resulting chromatogram was compatible with sickle cell disease, the child and the parents were referred for diagnostic confirmation and treatment. RESULTS: Between August 2000 and November 2001, 99 260 newborns were screened. There was one case of homozygous Hb C. On average, one of every 27 newborns who were screened presented sickle cell trait (Hb AS). Sickle cell disease was observed in 83 cases, or one new case in each 1 196 births. The 83 consisted of: 62 Hb S, 18 Hb SC, and 3 Hb SD. One child did not appear for diagnostic confirmation. The 82 children who were followed up by the program presented 15 intercurrent illnesses (upper respiratory infections, fever, splenic sequestration crises, hand-foot syndrome, and vascular occlusion), resulting in seven hospital admissions. Blood transfusions were necessary with 15 children, but none developed alloimmunization. All the other babies were doing well with the use of prophylactic penicillin. CONCLUSIONS: Our data show the importance of early diagnosis for sickle cell disease, so as to prevent the frequent infectious complications faced by these patients.

6591 downloads

Exibindo

itens por página

Página de 1 Próxima

Selecione um ou mais resultados

Todos Ordem alfabética

Resultados

Gráfico comparativo Download CSV

Visualizar estatísticas de

Enviar resultado

E-mail do(s) destinatários*

Utilize ; (ponto e vírgula) para mais de um e-mail.

Enviar por e-mail

Esta página

Registros selecionados

Todos os registros (max. 300)

Alterar remetente, assunto e comentários

Seu email

Assunto

Comentários

Alterar remetente, assunto e comentários

Exportar resultados

Formato de exportação:

RIS (para EndNote, ProCite, Reference Manager, RefWorks, Citavi, etc.)

BibTeX

Citação

CSV (para Excel, etc)

Exportar:

Esta página

Itens selecionados

Todos os registros (max. 2000)

Mostrar mais

Sem resultados

Não foram encontrados documentos para sua pesquisa

Glossário e ajuda para busca

Você pode enriquecer sua busca de uma forma muito simples. Use os índices de pesquisa combinados com os conectores (AND ou OR) e especifique cada vez mais sua busca.

Por exemplo, se você deseja buscar artigos sobre
casos de dengue no Brasil em 2015, use:
ti:dengue and publication_year:2015 and aff_country:Brasil

Veja abaixo a lista completa de índices de pesquisa que podem ser usados:

Cód. do Índice	Elemento
ti	título do artigo
au	autor
kw	palavras-chave do artigo
subject	assunto (palavras do título, resumo e palavras-chave)
ab	resumo
ta	título abreviado da revista (ex. Cad. Saúde Pública)
journal_title	título completo da revista (ex. Cadernos de Saúde Pública)
la	código do idioma da publicação (ex. pt - Português, es - Espanhol)
type	tipo do documento
pid	identificador da publicação
publication_year	ano de publicação do artigo
sponsor	financiador
aff_country	código do país de afiliação do autor
aff_institution	instituição de afiliação do autor
volume	volume do artigo
issue	número do artigo
elocation	elocation
doi	número DOI
issn	ISSN da revista
in	código da coleção SciELO (ex. scl - Brasil, col - Colômbia)
use_license	código da licença de uso do artigo

SciELO - Scientific Electronic Library Online
Rua Dr. Diogo de Faria, 1087 – 9º andar – Vila Clementino 04037-003 São Paulo/SP - Brasil
Email: scielo@scielo.org

Todo o conteúdo de www.scielo.org, exceto onde está identificado, está licenciado sob uma Licença Creative Commons.
saiba mais »